The first epinephrine autoinjector (EAI) has been approved by specifically for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and children weighing 7.5-15 kg. With a shorter needle length and dose specifically designed for infants, this autoinjector delivers the accurate dose timely and reduces the risk of injecting excess of epinephrine. Epinephrine autoinjector delivers measured doses of epinephrine mainly for emergency treatment of anaphylactic reactions.
However, there was no device to deliver an appropriate dose of epinephrine to infants and children till date, causing a potential delay in administration of epinephrine in a life-threatening allergic emergency. Dosage And Administration Epinephrine autoinjector (0.1 mg dose): Inject intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary.…
